Study of Dasatinib in Patients With Advanced Solid Tumors
The purpose of Segment 1 of the study is to determine the effect of ketoconazole on
dasatinib. The purpose of Segment 2 is to learn how dasatinib affects tumor growth in
patients with advanced solid tumors.
A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
The purpose of this clinical research study is to compare the confirmed complete cytogenetic
response of dasatinib with that of imatinib within 12 months after randomization in patients
with newly diagnosed chronic-phase Philadelphia positive chronic myeloid leukemia. The
safety of this treatment will also be studied.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.